207_Combined course Presentations
Hybrid study: SBRT with concurrent chemoradiation
Study design
Endpoints
Primary endpoint:
•
The Mean-lung dose (MLD) associated with 15% chance on radiation pneumonitis ≥G3 and dyspnea ≥G3
Secondary endpoints : Overall toxicity
•
Disease control
Courtesy of J. Belderbos
Made with FlippingBook